MHC
LBRX

Meyer Handelman Company’s LB Pharmaceuticals LBRX Stock Holding History

Meyer Handelman Company’s Portfolio LBRX Stock Details LBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$490K Hold
15,094
– – 0.01% 188
2026
Q1 		$372K Buy
+15,094
New +$348K 0.01% 190

Other funds holding LBRX

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Meyer Handelman Company's LBRX Position: Q2 2026 in Review

Meyer Handelman Company held its LB Pharmaceuticals (LBRX) position steady in Q2 2026 at 15,094 shares worth $490K. The position accounts for 0.01% of the portfolio, ranked #188.

Meyer Handelman Company first reported a position in LBRX in Q1 2026 and has held it in 2 quarters since. 115 funds tracked by Wall St. Rank hold LBRX as of Q2 2026.

  • Meyer Handelman Company held 15,094 shares of LB Pharmaceuticals worth $490K as of Q2 2026.
  • Meyer Handelman Company left its LB Pharmaceuticals share count unchanged in Q2 2026.
  • LB Pharmaceuticals made up 0.01% of Meyer Handelman Company's portfolio in Q2 2026, its #188 holding.
  • Meyer Handelman Company first reported a position in LB Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 115 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q2 2026.

Based on Meyer Handelman Company's 13F filing for Q2 2026, filed 3 Aug 2026.